EN
HI
Summary
As of 24 Oct, 2026, Samrat Pharmachem stock price is ₹279. During the trading session, the stock has moved between an intraday low of ₹260.10 and an intraday high of ₹289.00. Over the last 52 weeks, Samrat Pharmachem has traded between ₹190.00 and ₹309.85.
The stock has recorded a trading volume of 1,601 shares,. Its Average Traded Price (ATP) is ₹274.20, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 56 @ ₹279.00.
Samrat Pharmachem has an upper circuit limit of ₹316.90 and a lower circuit limit of ₹259.30. The total value traded stands at ₹4.39 L, and the delivery percentage for the day is 71.28%.
The stock is currently traded with a market lot size of 1. Samrat Pharmachem also offers a dividend yield of 0%.
Samrat Pharmachem Share Price Chart
Samrat Pharmachem Share Key Metrics
Volume
1601.00
Market Cap
85.74 CR
LTQ@LTP
56@279.00
ATP
274.2
Var Margin
25 %
Circuit Range
259.3-316.9
Delivery %
71.28 %
Value
4.39 L
ASM/GSM
No
Market Lot
1
Samrat Pharmachem Resistance and Support
Pivot 286.68
Resistance
First Resistance
295.41
Second Resistance
302.73
Third Resistance
311.46
Support
First Support
279.36
Second Support
270.63
Third Support
263.31
Samrat Pharmachem Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Oct 23 2026 | 289 | 279 | -3.16% | 289 | 260.1 |
| Thu Oct 22 2026 | 278 | 288.1 | 5.86% | 294 | 277.95 |
| Wed Oct 21 2026 | 271.89 | 272.14 | 0.74% | 283 | 265.7 |
Samrat Pharmachem Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-14 | Quarterly Results |
| 2026-08-14 | Quarterly Results |
| 2026-05-30 | Audited Results |
| 2026-02-13 | Quarterly Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-30 | Audited Results & Final Dividend |
| 2025-02-14 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
Samrat Pharmachem News
Samrat Pharmachem Ltd-$ - 530125 - Board Meeting Intimation for Board Meeting Intimation For Un-Audited Financial Results For The Quarter Ended September 30, 2026
Samrat Pharmachem board will convene on November 14, 2026, to consider and approve its Q2 FY27 financial results. This meeting will review the unaudited financial performance for the quarter ending September 30, 2026.
Sep 26 2026 15:12:12
Samrat Pharmachem Management
| Name | Position |
|---|---|
| Nishant Kankaria | Company Secretary & Compliance Officer |
| Lalit Mehta | Chairman & Managing Director |
Samrat Pharmachem FAQs
The Buying Price of Samrat Pharmachem share is 279 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Samrat Pharmachem stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Samrat Pharmachem, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Samrat Pharmachem shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Samrat Pharmachem shares is 0. Useful to assess the stock's value relative to its book value.
To assess Samrat Pharmachem’s valuation compare Sector P/E, P/B which are 38.79 & 3.22 with sector averages, along with growth rates and financial metrics.
The Market Cap of Samrat Pharmachem is 85.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Samrat Pharmachem share price is 309.85 & 190.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Samrat Pharmachem belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in SAMRATPH
